Danuta Jeziorska

Biotech CEO, Serial Entrepreneur, Inventor, Angel Investor & Gene regulation/Functional genomics for drug discovery expert

📍 United Kingdom🔄 Updated September 2026💼 1 investments📅 2 years investing🗓 Last invested Jul 2024
VC🌍 United Kingdom
1
Total investments
0
Early stage
0
Mid stage
0
Late stage
2y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Jul 2024
This is a catchall company for the doers, the thinkers, and the innovators.
Experience · 3 entries
All (3)
Investments (1)
Founder (2)
2024
Angel Investor
Jul 2024
This is a catchall company for the doers, the thinkers, and the innovators.
2018
CEO & Co-Founder
Feb 2018
Nucleome was founded in 2019. The precision of its 3D genomics technology has the potential to improve drug discovery success rates both by discovering genetically-validated medicines, and by more accurately identifying patients who are likely to benefit from treatments. Nucleome’s platform can be applied to multiple disease indications and cell types, with an initial focus on inflammatory conditions. In addition to building its own pipeline, the company is forging external collaborations in target discovery, target validation, and patient stratification. Nucleome was founded by leading experts in gene regulation from the University of Oxford. The Company is backed by a world-class syndicate of investors that includes M Ventures, the strategic corporate venture capital arm of Merck KGaA; Johnson and Johnson Innovation-JJDC, Inc. (“JJDC”), the strategic venture capital arm of Johnson & Johnson; Pfizer Ventures, the venture group of Pfizer; British Patient Capital; and founding investor Oxford Science Enterprises.
early stageBiotechnology
2017
Co-Founder and Senior Advisor, Innovation Forum Oxford
Jun 2017
The Innovation Forum is an international grassroots network that supports scientific entrepreneurs aiming to build ambitious companies at the intersection of science, technology and health. Their IMAGINE IF! initiative is a leading pre-acceleration programme for early-stage science-based ventures providing start-ups with extensive opportunities to take their venture to the next level through structured interactions with key stakeholders, tailored expert mentoring and connections with other founders and companies. Global branches: - UK: Cambridge, Oxford, London, Manchester - US: New York City - Switzerland: Lausanne - Spain: Barcelona - Serbia: Belgrade - China: Hong Kong - Bangladesh: Dhaka http://www.inno-forum.org/ Were always keen to hear from innovative minds: get in touch at info@inno-forum.org or check out our website at www.inno-forum.org Focussing on cutting edge: - Life Science, - Engineering, - Nanotechnology, - Computer Science - Green Biotech /Energy